A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Adults with Crohn's disease that is clinically active despite conventional treatment will be eligible for this study. Patients may receive one of three doses of PF-00547659 (experimental drug) or placebo (inactive drug). Disease activity will be measured every two weeks.
Inclusion Criteria:
Exclusion Criteria:
Chevy Chase, Maryland 20815, United States
Pasadena, Texas 77505, United States
Lübeck, 23538, Germany
Minato-ku, Tokyo 105-8471, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
Bydgoszcz, 85-168, Poland
Nitra, 949 01, Slovakia